Generic placeholder image

Current Nanoscience

Author(s): Smita D. More*, Anjali S. Wadhokar and Rushali S. Bedjawalge

DOI: 10.2174/1573413719666230605120659

DownloadDownload PDF Flyer Cite As
A Review on Solid Lipid Nanoparticles as Nano Drug Delivery Transporters

Page: [644 - 670] Pages: 27

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Solid lipid nanoparticles (SLN) have several potential uses in research for medicine such as drug discovery and drug delivery, an area at the forefront of evolving area of nanobiotechnology. In general, SLNs were created to address the drawbacks of conventional colloidal carriers, including emulsions, liposomes, and polymeric nanoparticles since they provide various advantages such as favourable release profiles and tailored drug delivery with outstanding physical-chemical stability. Solid lipid nanoparticles are spherical solid lipid particles that are distributed in water or an aqueous surfactant solution and are in the nanometer size range. Therefore, SLN is used to deliver hydrophilic and lipophilic drugs. The review article focuses on various aspects of SLN including the structure, the influence of excipients, the drug incorporation model, the principle of release, the method of preparation, characterization, the route of administration and biodistribution, and the application of SLN.

Keywords: Nanoparticles, nanotechnology, solid lipid nanoparticles, colloidal drug carrier, drug incorporation, applications.

Graphical Abstract

[1]
Anjum, R.; Lakshmi, P.K. A review on solid lipid nanoparticles; focus on excipients and formulation techniques. Int. J. Pharm. Sci. Res., 2019, 10(9), 4090.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.10]
[2]
Pragati, S.; Singh, K.; Ashok, K.; Sathees, M. Solid lipid nanoparticles: A promising drug delivery system. Int. J. Pharm. Sci. Nanotechnol., 2012, 2(2), 90-117. Available from: www.irjponline.com
[3]
Reddy, R.N.; Shariff, A. Solid lipid nanoparticles: An advanced drug delivery system. IJPSR, 2013, 4(1), 161-171. Available from: www.ijpsr.com
[4]
Surender, V.; Deepika, M. Solid lipid nanoparticles: A comprehensive review. Journal of Chemical and Pharmaceutical Research, 8(8), 102-114. Available from: www.jocpr.com
[5]
Alsaad, A.A.A.; Hussien, A.A.; Gareeb, M.M. Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review. Systematic Reviews in Pharmacy, 2020, 11(5), 259-273.
[6]
Khatak, S.; Goel, R.K.; Yadav, N.; Vir, U.; Sara, S. Solid lipid nanoparticles: A review. International Journal of Applied Pharmaceutics, 2013, 5(2), 8-18. Available from: https://www.researchgate.net/publication/287716187
[7]
Garud, A.; Singh, D.; Garud, N. Solid lipid nanoparticles (SLN): Method, characterization and applications. Int. Curr. Pharm. J., 2012, 1(11) Available From: http://www.icpjonline.com/documents/Vol1Issue11/08.pdf
[8]
Ekambaram, P.; Abdul, A.; Sathali, H.; Priyanka, K. Solid lipid nanoparticles: A review. Sci. Revs. Chem. Commun., 2012, 2(1), 80-102. Available from: www.sadgurupublications.com
[9]
Pandey, S.; Shaikh, F.; Gupta, A.; Tripathi, P.; Yadav, J.S. A recent update: Solid lipid nanoparticles for effective drug delivery. Adv. Pharm. Bull., 2022, 17-33.
[10]
Ramesh, Y.; Sekhar, C.; Reddy, J. A review on solid lipid nanoparticles. Int. J. Pharm. Drug Anal., 2016. Available from: http://ijpda.com
[11]
Severino, P.; Andreani, T.; Macedo, A.S.; Fangueiro, J.F.; Santana, M.H.A.; Silva, A.M.; Souto, E.B. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. J. Drug Deliv., 2012, 2012, 1-10.
[http://dx.doi.org/10.1155/2012/750891] [PMID: 22175030]
[12]
Naseri, N.; Valizadeh, H.; Zakeri-Milani, P. Solid lipid nanoparticles and nanostructured lipid carriers: Structure preparation and application. Adv. Pharm. Bull., 2015.
[13]
Manjunath, K.; Reddy, J.S.; Venkateswarlu, V. Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol., 2005, 27(2), 127-144.
[http://dx.doi.org/10.1358/mf.2005.27.2.876286] [PMID: 15834465]
[14]
Hanumanaik, M.; Kumar Patel, S.; Ramya Sree, K. Solid lipid nanoparticles; a review. IJPSR, 2013, 4(3), 928-940. Available from: www.ijpsr.com
[15]
Charan Teja, V.R. A glimpse on solid lipid nanoparticles as drug delivery systems. J. Glob. Trends Pharm. Sci., 2014, 5 Available from: www.jgtps.com
[16]
Lingayat, V.J.; Zarekar, N.S.; Shendge, R.S. Solid lipid nanoparticles: a review. Nanoscience and Nanotechnology Research, 2017, 4(2), 67-72. Available from: http://pubs.sciepub.com
[17]
Raut, I.D.; Doijad, R.C.; Mohite, S.K. Solid lipid nanoparticles: A promising drug delivery system. Int. J. Pharm. Sci. Res., 2018, 9(3), 862-871. [Internet].
[http://dx.doi.org/10.13040/IJPSR.0975-8232.9]
[18]
Ramteke, K.H.; Joshi, S.A.; Dhole, S.N. Solid lipid nanoparticle: a review. IOSR Journal of Pharmacy, 2012. Available from: www.iosrphr.org
[19]
Qushawy, M.; Nasr, A. Solid lipid nanoparticles (SLNs) as nano drug delivery carriers: Preparation, characterization and application. International Journal of Applied Pharmaceutics, 2020, 12, 1-9.
[20]
Swathi, G.; Prasanthi, N.L.; Manikiran, S.S.; Ramarao, N. Solid lipid nanoparticles: Colloidal carrier systems for drug delivery. Int. J. Pharm. Sci. Res., 2010, 1(12) Available from: www.ijpsr.com
[21]
Yadav, P.; Soni, G.; Mahor, A.; Alok, S.; Singh, P.P.; Verma, A. Solid lipid nanoparticles: An effective and promising drug delivery system-a review. Int. J. Pharm. Sci. Res., 2014, 5(4), 1152. [Internet].
[http://dx.doi.org/10.13040/IJPSR.0975-8232.5]
[22]
Mahajan, P.S.; Mahajan, K.B.; Darekar, A.B. A review on solid lipid nanoparticle (SLN): An advanced treatment modality. Int. J. Pharm. Sci. Res., 2015, 6(9), 3698.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.6]
[23]
Kadam, N.N.; Patil, R.R.; Gaikwad, S.S.; Wagh, M.P.; Kadam, N. Recent prospective on solid lipid nanoparticles and its application-A review. Indo American Journal of Pharmaceutical Research, 2017, 2017(3), 7. Available from: www.iajpr.com
[24]
Mishra, V.; Bansal, K.K.; Verma, A.; Yadav, N.; Thakur, S.; Sudhakar, K. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics, 2018, 10(4), 191.
[25]
Sonali, S.; Yogita, I.; Sharda, G.; Amit, C.; Shital, A. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Int. J. Creative Res. Thoughts, 2021. Available from: www.ijcrt.org
[26]
Rai, S.; Paliwal, R.; Gupta, P.N.; Khatri, K.; Goyal, A.K.; Vyas, S.P. Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr. Nanosci., 2008, 4(1), 30-44.
[27]
Sharma, V.K.; Diwan, A.; Sardana, S.; Dhall, V. Solid lipid nanoparticles system: An overview. 2011. Available from: www.ijrps.pharmascope.org
[28]
Das, S.; Chaudhury, A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech, 2011, 12(1), 62-76.
[http://dx.doi.org/10.1208/s12249-010-9563-0] [PMID: 21174180]
[29]
Bhatt, S.; Sharma, J.; Singh, M.; Saini, V. Solid lipid nanoparticles: A promising technology for delivery of poorly water-soluble drugs. ACTA Pharmaceutica Sciencia, 2018, 56(3), 27-49.
[http://dx.doi.org/10.23893/1307-2080.APS.05616]
[30]
Karamchedu, S.; Tunki, L.; Kulhari, H.; Pooja, D. Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability. Chem. Phys. Lipids, 2020, 233, 104988.
[http://dx.doi.org/10.1016/j.chemphyslip.2020.104988] [PMID: 33035545]
[31]
Jain, A.; Sharma, G.; Thakur, K.; Raza, K.; Shivhare, U.S.; Ghoshal, G.; Katare, O.P. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: An Investigative Assessment. AAPS PharmSciTech, 2019, 20(3), 100.
[http://dx.doi.org/10.1208/s12249-019-1301-7] [PMID: 30721373]
[32]
Jalilian, M.; Derakhshandeh, K.; Kurd, M.; Lashani, H. Targeting Solid Lipid Nanoparticles with Anisamide for Docetaxel Delivery to Prostate Cancer: Preparation, Optimization, and In-vitro Evaluation. Iran. J. Pharm. Res., 2021, 20(1), 327-338.
[PMID: 34400962]
[33]
Mahmoudian, M.; Valizadeh, H.; Zakeri-Milani, P. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation. Drug Dev. Ind. Pharm., 2018, 44(10), 1598-1605.
[http://dx.doi.org/10.1080/03639045.2018.1483385] [PMID: 29874944]
[34]
Jansook, P.; Fülöp, Z.; Ritthidej, G.C. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. Drug Dev. Ind. Pharm., 2019, 45(4), 560-567.
[http://dx.doi.org/10.1080/03639045.2019.1569023] [PMID: 30632399]
[35]
Shah, M.; Agrawal, Y.K.; Garala, K.; Ramkishan, A.A. Solid lipid nanoparticles of a water-soluble drug, ciprofloxacin hydrochloride. Indian J. Pharm. Sci., 2012, 74(5), 434-442. Available from: www.ijpsonline.com
[36]
Ghaderkhani, J.; Yousefimashouf, R.; Arabestani, M.; Roshanaei, G.; Asl, S.S.; Abbasalipourkabir, R. Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus. Artif. Cells Nanomed. Biotechnol., 2019, 47(1), 1181-1193.
[http://dx.doi.org/10.1080/21691401.2019.1593858] [PMID: 30942627]
[37]
Tian, H.; Lu, Z.; Li, D.; Hu, J. Preparation and characterization of citral-loaded solid lipid nanoparticles. Food Chem., 2018, 248, 78-85.
[http://dx.doi.org/10.1016/j.foodchem.2017.11.091] [PMID: 29329873]
[38]
Valizadeh, A.; Khaleghi, A.A.; Roozitalab, G.; Osanloo, M. High anticancer efficacy of solid lipid nanoparticles containing Zataria multiflora essential oil against breast cancer and melanoma cell lines. BMC Pharmacol. Toxicol., 2021, 22(1), 52.
[http://dx.doi.org/10.1186/s40360-021-00523-9] [PMID: 34587996]
[39]
Silva, E.L.; Carneiro, G.; de Araújo, L.A.; de Jesus, M.; Trindade, V.; Yoshida, M.I. OrÉFice, R.L.; de Macêdo Farias, L.; de Carvalho, M.A.R.; Santos, S.G.D.; Assis, G.; Goulart, C.; Alves, R.J.; Ferreira, L.A.M. Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris. J. Nanosci. Nanotechnol., 2015, 15(1), 792-799.
[http://dx.doi.org/10.1166/jnn.2015.9184] [PMID: 26328443]
[40]
Hosseini, S.M.; Farmany, A.; Abbasalipourkabir, R.; Soleimani Asl, S.; Nourian, A.; Arabestani, M.R. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study. Ann. Clin. Microbiol. Antimicrob., 2019, 18(1), 33.
[http://dx.doi.org/10.1186/s12941-019-0333-x] [PMID: 31706304]
[41]
Guo, D.; Dou, D.; Li, X.; Zhang, Q.; Bhutto, Z.A.; Wang, L. Ivermection-loaded solid lipid nanoparticles: preparation, characterisation, stability and transdermal behaviour. Artif. Cells Nanomed. Biotechnol., 2018, 46(2), 255-262.
[http://dx.doi.org/10.1080/21691401.2017.1307207] [PMID: 28368657]
[42]
Masiiwa, W.L.; Gadaga, L.L. Intestinal Permeability of Artesunate-Loaded Solid Lipid Nanoparticles Using the Everted Gut Method. J. Drug Deliv., 2018, 2018, 1-9.
[http://dx.doi.org/10.1155/2018/3021738] [PMID: 29854465]
[43]
Bhattacharyya, S.; Reddy, P. Effect of surfactant on azithromycin dihydrate loaded stearic acid solid lipid nanoparticles. Turkish Journal of Pharmaceutical Sciences, 2019, 16(4), 425-431.
[http://dx.doi.org/10.4274/tjps.galenos.2018.82160] [PMID: 32454745]
[44]
Jourghanian, P.; Ghaffari, S.; Ardjmand, M.; Haghighat, S.; Mohammadnejad, M. Sustained release curcumin loaded solid lipid nanoparticles. Adv. Pharm. Bull., 2016, 6(1), 17-21. Available from: http://apb.tbzmed.ac.ir
[http://dx.doi.org/10.15171/apb.2016.04]
[45]
Ekambaram, P.; Abdul Hasan Sathali, A. Formulation and evaluation of solid lipid nanoparticles of ramipril. J. Young Pharm., 2011, 3(3), 216-220.
[http://dx.doi.org/10.4103/0975-1483.83765] [PMID: 21897661]
[46]
Singh, S.; Dobhal, A.K.; Jain, A.; Pandit, K.; Chakraborty, S. Formulation and evaluation of solid lipid nanoparticles of a water-soluble drug. Zidovudine. Regular Article Chem. Pharm. Bull, 2010, 58(5), 650-655.
[47]
Eldeen, A.; Yassin, B.; Khalid Anwer, M.; Mowafy, H.A.; El-Bagory, I.M.; Bayomi, M.A. Optimization of 5-flurouracil solid-lipid nanoparticles: A preliminary study to treat colon cancer. Int. J. Med., 2010, 7(6), 398.
[48]
Kim, S.T.; Jang, D.J.; Kim, J.H.; Park, J.Y.; Lim, J.S.; Lee, S.Y.; Lee, K.M.; Lim, S.J.; Kim, C.K. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Pharmazie, 2009, 64(8), 510-514.
[PMID: 19746839]
[49]
Dhawan, S.; Kapil, R.; Singh, B. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol., 2011, 63(3), 342-351.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01225.x] [PMID: 21749381]
[50]
Hao, J.; Fang, X.; Zhou, Y.; Wang, J.; Guo, F.; Li, F.; Peng, X. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int. J. Nanomedicine, 2011, 6, 683-692.
[PMID: 21556343]
[51]
Emami, J.; Mohiti, H.; Hamishehkar, H.; Varshosaz, J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res. Pharm. Sci., 2015, 10(1), 17-33.
[PMID: 26430454]
[52]
Eskandani, M.; Barar, J.; Ezzati Nazhad Dolatabadi, J.; Hamishehkar, H.; Nazemiyeh, H. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles. Pharm. Biol., 2015, 53(10), 1525-1538.
[http://dx.doi.org/10.3109/13880209.2014.991836] [PMID: 25853953]
[53]
Kumar, V.V.; Chandrasekar, D.; Ramakrishna, S.; Kishan, V.; Rao, Y.M.; Diwan, P.V. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. Int. J. Pharm., 2007, 335(1-2), 167-175.
[http://dx.doi.org/10.1016/j.ijpharm.2006.11.004] [PMID: 17161566]
[54]
Naguib, Y.W.; Rodriguez, B.L.; Li, X.; Hursting, S.D.; Williams, R.O., III; Cui, Z. Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Mol. Pharm., 2014, 11(4), 1239-1249.
[http://dx.doi.org/10.1021/mp4006968] [PMID: 24621456]
[55]
Mante, P.K.; Adomako, N.O.; Antwi, P.; Kusi-Boadum, N.K.; Osafo, N. Solid-lipid nanoparticle formulation improves antiseizure action of cryptolepine. Biomed. Pharmacother., 2021, 137, 111354.
[http://dx.doi.org/10.1016/j.biopha.2021.111354] [PMID: 33561642]
[56]
Ezzati Nazhad Dolatabadi, J.; Hamishehkar, H.; Eskandani, M.; Valizadeh, H. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloids Surf. B Biointerfaces, 2014, 117, 21-28.
[http://dx.doi.org/10.1016/j.colsurfb.2014.01.055] [PMID: 24607519]
[57]
Mohsen, A.; Kumar, P.P.; Gayatri, P.; Sunil, R.; Jaganmohan, S.; Rao, Y.M. Atorvastatin loaded solid lipid nanoparticles: Formulation, optimization, and in-vitro characterization. IOSR J. Pharm., 2012, 2(5), 23-32. Available from: www.iosrphr.org
[58]
Rawat, M.K.; Jain, A.; Singh, S. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. J. Pharm. Sci., 2011, 100(6), 2366-2378.
[http://dx.doi.org/10.1002/jps.22435] [PMID: 21491449]
[59]
Chalikwar, S.S.; Belgamwar, V.S.; Talele, V.R.; Surana, S.J.; Patil, M.U. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf. B Biointerfaces, 2012, 97, 109-116.
[http://dx.doi.org/10.1016/j.colsurfb.2012.04.027] [PMID: 22609590]
[60]
Ibrahim, W.M.; AlOmrani, A.H.; Yassin, A.E.B. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int. J. Nanomedicine, 2014, 9(1), 129-144.
[PMID: 24379671]
[61]
Chen, R.; Wang, S.; Zhang, J.; Chen, M.; Wang, Y. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Deliv., 2015, 22(5), 666-674.
[http://dx.doi.org/10.3109/10717544.2014.882446] [PMID: 24512431]
[62]
Varshosaz, J.; Tabbakhian, M.; Mohammadi, M.Y. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J. Liposome Res., 2010, 20(4), 286-296.
[http://dx.doi.org/10.3109/08982100903443065] [PMID: 19958118]
[63]
Nazemiyeh, E.; Eskandani, M.; Sheikhloie, H.; Nazemiyeh, H. Formulation and physicochemical characterization of lycopene-loaded solid lipid nanoparticles. Adv. Pharm. Bull., 2016, 6(2), 235-241.
[http://dx.doi.org/10.15171/apb.2016.032] [PMID: 27478786]
[64]
Bhalekar, M.; Upadhaya, P.; Madgulkar, A. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Appl. Nanosci., 2017, 7(1-2), 47-57.
[http://dx.doi.org/10.1007/s13204-017-0547-1]
[65]
Parveen, R.; Ahmad, F.J.; Iqbal, Z.; Samim, M.; Ahmad, S. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev. Ind. Pharm., 2014, 40(9), 1206-1212.
[http://dx.doi.org/10.3109/03639045.2013.810636] [PMID: 23826860]
[66]
Delgado, D.; del Pozo-Rodríguez, A.; Solinís, M.Á.; Rodríguez-Gascón, A. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway. Eur. J. Pharm. Biopharm., 2011, 79(3), 495-502.
[http://dx.doi.org/10.1016/j.ejpb.2011.06.005] [PMID: 21726641]
[67]
Vijayan, V.; Aafreen, S.; Sakthivel, S.; Reddy, K.R. Formulation and characterization of solid lipid nanoparticles loaded Neem oil for topical treatment of acne. J. Acute Dis., 2013, 2(4), 282-286.
[http://dx.doi.org/10.1016/S2221-6189(13)60144-4]
[68]
Sarmento, B.; Martins, S.; Ferreira, D.; Souto, E.B. Oral insulin delivery by means of solid lipid nanoparticles. Int. J. Nanomedicine, 2007, 2(4), 743-749.
[PMID: 18203440]
[69]
Hou, D.; Xie, C.; Huang, K.; Zhu, C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 2003, 24(10), 1781-1785.
[http://dx.doi.org/10.1016/S0142-9612(02)00578-1] [PMID: 12593960]
[70]
Patravale, V.B.; Mirani, A.G. Preparation and characterization of solid lipid nanoparticles-based gel for topical delivery.Methods in Molecular Biology; Humana Press Inc., 2019, pp. 293-302.
[71]
Raut, I.D.; Doijad, R.C.; Mohite, S.K.; Manjappa, A.S. Preparation and Characterization of Solid Lipid Nanoparticles Loaded with Cisplatin. J. Drug Deliv. Ther., 2018, 8(6), 125-131.
[http://dx.doi.org/10.22270/jddt.v8i6.2033]
[72]
Singh, S.; Kushwaha, A.K.; Vuddanda, P.R.; Karunanidhi, P.; Singh, S.K. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res. Int., 2013.
[73]
Sultana, S.; Mohammed, S. Formulation and in-vitro evaluation of solid lipid nanoparticles containing Nadolol. Int. J. Pharm. Sci. Res., 2022, 13(7), 2717.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.13]
[74]
Tiyaboonchai, W.; Tungpradit, W.; Plianbangchang, P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm., 2007, 337(1-2), 299-306.
[http://dx.doi.org/10.1016/j.ijpharm.2006.12.043] [PMID: 17287099]
[75]
Hasan, N.; Imran, M.; Kesharwani, P.; Khanna, K.; Karwasra, R.; Sharma, N.; Rawat, S.; Sharma, D.; Ahmad, F.J.; Jain, G.K.; Bhatnagar, A.; Talegaonkar, S. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int. J. Pharm., 2021, 599, 120428.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120428] [PMID: 33662465]
[76]
Soma, D.; Attari, Z.; Reddy, M.S.; Damodaram, A.; Koteshwara, K.B.G. Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies. Braz. J. Pharm. Sci., 2017, 53(1), e15012.
[http://dx.doi.org/10.1590/s2175-97902017000115012]
[77]
Aljaeid, B.; Hosny, K.M. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Int. J. Nanomedicine, 2016, 11, 441-447.
[http://dx.doi.org/10.2147/IJN.S100625] [PMID: 26869787]
[78]
El-Say, K.M.; Hosny, K.M. Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits. PLoS One, 2018, 13(8), e0203405.
[http://dx.doi.org/10.1371/journal.pone.0203405] [PMID: 30161251]
[79]
El-Housiny, S.; Shams Eldeen, M.A.; El-Attar, Y.A.; Salem, H.A.; Attia, D.; Bendas, E.R.; El-Nabarawi, M.A. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. Drug Deliv., 2018, 25(1), 78-90.
[http://dx.doi.org/10.1080/10717544.2017.1413444] [PMID: 29239242]
[80]
Dhome, A.G.; Deshkar, S.S.; Shirolkar, S.V. Gliclazide Solid Lipid Nanoparticles: Formulation, Optimization and in vitro Characterization. Pharm. Res., 2018, 1(1), 8-16.
[81]
Londhe, V. Zaltoprofen loaded solid lipid nanoparticles for topical delivery: Formulation design, in vitro and ex vivo evaluation. MOJ Bioequivalence & Bioavailability, 2017, 4(2)
[82]
Karami, M.A.; Sharif Makhmal Zadeh, B.; Koochak, M.; Moghimipur, E. Superoxide dismutase-loaded solid lipid nanoparticles prepared by cold homogenization method: Characterization and permeation study through burned rat skin. Jundishapur J. Nat. Pharm. Prod., 2016, 11(4)
[http://dx.doi.org/10.17795/jjnpp-33968]
[83]
Krishnatreyya, H.; Dey, S.; Pal, P.; Das, P.J.; Sharma, V.K.; Mazumder, B. Piroxicam loaded solid lipid nanoparticles (SLNs): Potential for topical delivery. Indian J. Pharm. Educ. Res., 2019, 53(2s), s82-s92.
[http://dx.doi.org/10.5530/ijper.53.2s.52]
[84]
Anjum, R.; Lakshmi, P. Dolutegravir sodium loaded solid lipid nanoparticles: A vaginal drug delivery system for pre-exposure prophylaxis of HIV. J. Res. Pharm., 2020, 24(4), 552-561.
[http://dx.doi.org/10.35333/jrp.2020.203]
[85]
Ruckmani, K.; Sivakumar, M.; Ganeshkumar, P.A. Methotrexate loaded Solid Lipid Nanoparticles (SLN) for effective treatment of carcinoma. J. Nanosci. Nanotechnol., 2006, 6(9-10), 2991-2995.
[86]
Sun, Y.; Li, L.; Xie, H.; Wang, Y.; Gao, S.; Zhang, L.; Bo, F.; Yang, S.; Feng, A. Primary studies on construction and evaluation of ion-sensitive in situ gel loaded with Paeonol-solid lipid nanoparticles for intranasal drug delivery. Int. J. Nanomedicine, 2020, 15, 3137-3160.
[http://dx.doi.org/10.2147/IJN.S247935] [PMID: 32440115]
[87]
da Rocha, M.C.O.; da Silva, P.B.; Radicchi, M.A.; Andrade, B.Y.G.; de Oliveira, J.V.; Venus, T.; Merker, C.; Estrela-Lopis, I.; Longo, J.P.F.; Báo, S.N. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells. J. Nanobiotechnology, 2020, 18(1), 43.
[http://dx.doi.org/10.1186/s12951-020-00604-7] [PMID: 32164731]
[88]
Khoiriyah, M. Ilham Kuncahyo; Kuncahyo, I. Jason Merari Perangirangin. Fenofibrate Characterization of Solid Lipid Nanoparticles Using the High Shear Homogenization Method. Nat. Sci. Eng. Technol. J., 2022, 2(2), 79-86.
[http://dx.doi.org/10.37275/nasetjournal.v2i2.21]
[89]
Kipriye, Z.; Şenel, B.; Yenilmez, E. Preparation and evaluation of carvedilol-loaded solid lipid nanoparticles for targeted drug delivery. Trop. J. Pharm. Res., 2017, 16(9), 2057-2068.
[http://dx.doi.org/10.4314/tjpr.v16i9.4]
[90]
Patel, P.; Raval, M.; Sheth, N. Silibinin loaded solid lipid nanoparticles: effect of different lipids and surfactants on physicochemical properties of nanoparticle. Int. J. Pharm. Investig., 2020, 10(3), 332-338.
[http://dx.doi.org/10.5530/ijpi.2020.3.59]
[91]
Nair, R.; Kumar, A.C.K.; Priya, V.K.; Yadav, C.M.; Raju, P.Y. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine. Lipids Health Dis., 2012, 11(1), 72.
[http://dx.doi.org/10.1186/1476-511X-11-72] [PMID: 22695222]
[92]
Khan, Z.U.; Razzaq, A.; Khan, A.; Rehman, N.U.; Khan, H.; Khan, T.; Khan, A.U.; Althobaiti, N.A.; Menaa, F.; Iqbal, H.; Khan, N.U. Physicochemical characterizations and pharmacokinetic evaluation of pentazocine solid lipid nanoparticles against inflammatory pain model. Pharmaceutics, 2022, 14(2), 409.
[http://dx.doi.org/10.3390/pharmaceutics14020409] [PMID: 35214141]
[93]
Rarokar, N.R.; Menghani, S.S.; Kerzare, D.R.; Khedekar, P.B.; Bharne, A.P.; Alamri, A.S.; Alsanie, W.F.; Alhomrani, M.; Sreeharsha, N.; Asdaq, S.M.B. Preparation of terbinafin-encapsulated solid lipid nanoparticles containing antifungal carbopol® hydrogel with improved efficacy: in vitro, ex vivo and in vivo study. Pharmaceutics, 2022, 14(7), 1393.
[http://dx.doi.org/10.3390/pharmaceutics14071393] [PMID: 35890289]
[94]
Nair, A.; Shah, J.; Al-Dhubiab, B.; Jacob, S.; Patel, S.; Venugopala, K.; Morsy, M.; Gupta, S.; Attimarad, M.; Sreeharsha, N.; Shinu, P. Clarithromycin solid lipid nanoparticles for topical ocular therapy: Optimization, evaluation, and in vivo studies. Pharmaceutics, 2021, 13(4), 523.
[http://dx.doi.org/10.3390/pharmaceutics13040523] [PMID: 33918870]
[95]
Bayat, P.; Pakravan, P.; Salouti, M.; Ezzati Nazhad Dolatabadi, J. Lysine decorated solid lipid nanoparticles of Epirubicin for cancer targeting and therapy. Adv. Pharm. Bull., 2020, 11(1), 96-103.
[http://dx.doi.org/10.34172/apb.2021.010] [PMID: 33747856]
[96]
El-Emam, G.A.; Girgis, G.N.S.; Hamed, M.F.; El-Azeem Soliman, O.A.; Abd El Gawad, A.E.G.H. Formulation and pathohistological study of Mizolastine–solid lipid nanoparticles–loaded ocular hydrogels. Int. J. Nanomedicine, 2021, 16, 7775-7799.
[http://dx.doi.org/10.2147/IJN.S335482] [PMID: 34853513]
[97]
Wang, J.; Wang, H.; Xu, H.; Li, J.; Zhang, X.; Zhang, X. Solid lipid nanoparticles as an effective sodium aescinate delivery system: formulation and anti-inflammatory activity. RSC Advances, 2022, 12(11), 6583-6591.
[http://dx.doi.org/10.1039/D1RA07638H] [PMID: 35424603]
[98]
Shah, P.; Chavda, K.; Vyas, B.; Patel, S. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Deliv. Transl. Res., 2021, 11(3), 1166-1185.
[http://dx.doi.org/10.1007/s13346-020-00839-9] [PMID: 32804301]
[99]
Rasouliyan, F.; Eskandani, M.; Jaymand, M.; Akbari Nakhjavani, S.; Farahzadi, R.; Vandghanooni, S.; Eskandani, M. Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles. Chem. Phys. Lipids, 2021, 239, 105123.
[http://dx.doi.org/10.1016/j.chemphyslip.2021.105123] [PMID: 34403685]
[100]
Landh, E.; Moir, L.M.; Traini, D.; Young, P.M.; Ong, H.X. Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part II: The effect of nanoparticle charge. Nanomedicine (Lond.), 2020, 15(20), 1947-1963.
[http://dx.doi.org/10.2217/nnm-2020-0192] [PMID: 32812483]
[101]
Fatouh, A.; Elshafeey, A.; Abdelbary, A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des. Devel. Ther., 2017, 11, 1815-1825.
[http://dx.doi.org/10.2147/DDDT.S102500] [PMID: 28684900]
[102]
Zhao, E; Yi, T; Du, J; Wang, J Experimental study on the resistance of synthetic penicillin solid lipid nanoparticles to clinically resistant Staphylococcus aureus. Comput Math Methods Med., 2021, 2021
[103]
Netto MPharm. G.; Jose, J.; Jose, J. Development, characterization, and evaluation of sunscreen cream containing solid lipid nanoparticles of silymarin. J. Cosmet. Dermatol., 2018, 17(6), 1073-1083.
[http://dx.doi.org/10.1111/jocd.12470] [PMID: 29226503]
[104]
Baek, J.S.; Na, Y.G.; Cho, C.W. Sustained cytotoxicity of wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles. Nanomaterials (Basel), 2018, 8(3), 159.
[http://dx.doi.org/10.3390/nano8030159] [PMID: 29533979]
[105]
Advantages and problems of SLNs and other nanoparticles. Available From: www.ijpsonline.com
[106]
Pardeshi, C.; Rajput, P.; Belgamwar, V.; Tekade, A.; Patil, G.; Chaudhary, K.; Sonje, A. Solid lipid based nanocarriers: An overview/Nanonosači na bazi čvrstih lipida: Pregled. Acta Pharm., 2012, 62(4), 433-472.
[http://dx.doi.org/10.2478/v10007-012-0040-z] [PMID: 23333884]
[107]
Kaur, I.P.; Kakkar, V.; Sandhu, S.K.; Gupta, T. The solid lipid nanoparticle of curcumin. WO109989A1, 2020.
[108]
Josep, L.V.P.; Gonzalez, R.D.; Botello, A.F. Lipid nanoparticle capsules. US0017239A1, 2013.
[109]
Weiss, J.; Maier, C.; Kessler, A.; Tedeschi, C.; Leuenberger, B.; Novotny, M. Solid lipid nanoparticles (II). US0030305A1, 2016.
[110]
Cal, K.; Wosicka, H. Solid lipid nanoparticles of roxithromycin for hair loss or acne. WO077712A1, 2014.
[111]
Weiss, J.; Schweiggert, C.; Leuenberger, B.; Novotny, M.; Tedeschi, C.; Kessler, A. Solid lipid nanoparticles. US9616001B2, 2017.
[112]
Delhi, N. Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins. US9907758B2, 2018.
[113]
Bhandari, R. Indu Pal Kaur. Solid lipid nanoparticles entrapping hydrophilic Amphiphilic drug and a process for preparing the same. WO105101, 2013.
[114]
Repka, M.A.; Patil, H.G.; Majumdar, S.; Park, J-B.; Kulkarni, V.I. Systems and methods for preparing solid lipid nanoparticles. US0172937A1, 2017.
[115]
Rainer, H. Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same. US8663692B1, 2014.
[116]
Diorio, C.; Lokhnauth, J. Curcumin solid lipid particles and methods for their preparation and use. US0036248A1, 2018.
[117]
Anil, B. Lipid nanoparticles (SLN, NLC): A novel approach for cosmetic and dermal pharmaceutical. J. Global Pharma Technol., 2010. Available from: www.jgpt.co.in
[118]
Ahmad, J. Lipid nanoparticles-based cosmetics with potential application in alleviating skin disorders. Cosmetics, 2021, 8(3), 84.